Overview

Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury

Status:
Terminated

Trial end date:
2021-02-12

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test the hypothesis that isosorbide mononitrate prevents deterioration of renal function in patients receiving anti-angiogenic therapies that target vascular endothelial growth factor (VEGF).

Phase:

Phase 2

Details

Lead Sponsor:

The University of Texas Health Science Center, Houston

Collaborator:

National Kidney Foundation

Treatments:

Endothelial Growth Factors
Isosorbide
Isosorbide Dinitrate
Isosorbide-5-mononitrate
Mitogens